Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alirocumab
2
×
biotech
2
×
boston blog main
life sciences
national blog main
new york blog main
new york top stories
regeneron pharmaceuticals
alex azar
alnylam pharmaceuticals
american patients first
amgen
biosimilars
boston top stories
boulder/denver blog main
boulder/denver top stories
center for medicare and medicaid services
clinical trials
craig garthwaite
cvs health
department of health and human services
detroit blog main
detroit top stories
donald trump
drug prices
drugs
evercore isi
evolocumab
express scripts
fda
food and drug administration
generic drugs
health insurance
heart attack
inclisiran
indiana blog main
indiana top stories
joseph swartz
medicare
medicines co.
What
drug
long
2
×
afternoon
alnylam
anticipated
awaited
based
blueprint
cholesterol
cost
cut
data
details
drugs
evidence
heart
house
lasting
looms
lower
lowering
meant
medco
medicines
new
partner
pharmaceuticals
plan
pledges
prescription
presented
president
prices
reckoning
rna
short
speech
supporting
term
touts
Language
Current search:
biotech
×
long
×
alirocumab
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
